Serious neurologic complications are uncommon among young children with influenza but occur more often among those with ...

Fulgent Genetics (NASDAQ:FLGT – Get Free Report) is anticipated to issue its quarterly earnings data before the market opens on Friday, February 28th. Analysts expect the company to announce earnings ...

We recently published a list of 10 Best Small-Cap Growth Stocks to Buy Now. In this article, we are going to take a look at ...

Researchers identify predictive markers of response to immunotherapy treatment in a study involving data from over 700 patients across six different cohorts. The study has significant relevance, ...

Ctexli’s approval further entrenches Mirum as a leader in rare liver diseases, alongside its cornerstone product Livmarli and ...

Mirum Pharmaceuticals’ Ctexli (chenodiol) has gained US Food and Drug Administration (FDA) approval for treating adults with ...

Baptist Memorial Hospital-Union County premiered a new leading-edge robotic technology that has the potential to enhance ...

The FDA has approved Ctexli for the treatment of cerebrotendinous xanthomatosis (CTX), a rare lipid storage disease, in ...

When Dr. Tom Sonderman was diagnosed with a urologic problem, he sought the care and treatment of Columbus Regional Health ...

Researchers explored how Pluvicto is used in the community and academic settings and when given by oncologists or urologists.

In Friday’s Health headlines, why hair dye exposure may be a health hazard and a potential cause of cancer. Dr. Michael ...